Coverage for its long-acting insulin, Levamir, dropped from 90% to about 35% when the company dropped its list price by 65%.

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving ...

The European Commission (EC) has granted marketing authorisation to Leo Pharma ’s Anzupgo (delgocitinib) cream for treating ...

Iterum Therapeutics faces a mixed reception for its therapy for uncomplicated urinary tract infections (UTIs) as experts ...

Telix has paid an upfront cost of $230m to acquire 31 licenced radiopharmacies from RLS located across the US.

Takeda has secured the Japanese MHLW approval for its FRUZAQLA to treat unresectable advanced or recurrent colorectal cancer ...

UCB has received US FDA approval for BIMZELX (bimekizumab-bkzx) to treat adults with three inflammatory conditions.

Discover how Memorial Sloan Kettering's new patent for innovative compounds could revolutionize treatments for Chagas disease, malaria, and sleeping sickness.

Discover CytomX Therapeutics' groundbreaking patent for innovative polypeptides with cleavable moieties, enhancing therapeutic and diagnostic applications.

Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

Discover Lyell Immunopharma's groundbreaking patent for EGFR-derived polypeptides, enhancing cancer treatment through innovative nucleic acid technologies and engineered T cells.

Inovio Pharmaceuticals secures a patent for innovative nucleic acid molecules targeting Survivin-expressing tumors, paving the way for advanced cancer therapies and vaccines.